4 recruiting, 1 active not recruiting, 1 completed, 1 withdrawn. 7 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Recruiting 4, Active not recruiting 1, Completed 1, Withdrawn 1 |
Follow Candid Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With Rheumatic Diseases CND319 - Healthy Participants Study, Rheumatoid Arthritis | Phase 1 | Recruiting | Candid Therapeutics | 105 | 2026-07-22 | 2026-10-21 |
| A Clinical Study of Cizutamig in Thyroid Eye Disease Cizutamig will be dosed according to the protocol. - Thyroid Eye Disease, TED | Phase 1 | Recruiting | Candid Therapeutics | 38 | 2026-05-08 | 2026-09-01 |
| A Phase 1 Study of Cizutamig in IgE Mediated Diseases Cizutamig - IgE-Mediated Hypersensitivity, IgE Mediated Food Allergy | Phase 1 | Withdrawn | Candid Therapeutics | 2026-04-01 | 2026-07-22 | |
| Absolute Bioavailability Study of Cizutamig in Healthy Adult Participants cizutamig, Placebo - Healthy Participants Study | Phase 1 | Completed | Candid Therapeutics | 24 | 2025-12-04 | 2026-07-22 |
| Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG) Cizutamig - Generalized Myasthenia Gravis | Phase 1 | Recruiting | Candid Therapeutics | 44 | 2025-09-16 | 2026-09-02 |
| Clinical Study of Cizutamig in Systemic Lupus Erythematosus Cizutamig - Systemic Lupus Erythematosus (SLE) | Phase 1 | Recruiting | Candid Therapeutics | 47 | 2025-09-04 | 2026-09-02 |
| An Open-label Study of CND261 in Seropositive Rheumatoid Arthritis CND261 - Rheumatoid Arthritis | Phase 1 | Active not recruiting | Candid Therapeutics | 47 | 2025-06-16 | 2026-09-03 |
Arthritis, Rheumatoid (2) · Asthma (1) · Dermatitis, Atopic (1) · Egg Hypersensitivity (1) · Food Hypersensitivity (1) · Graves Ophthalmopathy (1) · Hypersensitivity, Immediate (1) · Lupus Erythematosus, Systemic (1) · Milk Hypersensitivity (1) · Myasthenia Gravis (1) · Nut Hypersensitivity (1) · Peanut Hypersensitivity (1) · Rhinitis, Allergic (1) · Rhinosinusitis (1) · Sjogren's Syndrome (1)
Australia (3) · China (3) · Moldova (1) · Ukraine (1)